PEMF Therapy in Shoulder Tendinopathy - NCT07550543
Summary
This ClinicalTrials.gov registry entry documents a randomized controlled trial evaluating whether pulsed electromagnetic field (PEMF) therapy via the Super Inductive System (SIS), added to a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies. The study will compare participants receiving standard balneophysiotherapy against those receiving the same treatment supplemented with PEMF (SIS) therapy. Evaluations occur at baseline, discharge, and 4 weeks post-treatment using validated clinical instruments.
“The goal of this clinical trial is to evaluate whether pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS), integrated into a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This is a new clinical trial registry entry on ClinicalTrials.gov describing a randomized controlled trial investigating the efficacy of PEMF (SIS) therapy as an adjunct to multimodal rehabilitation for shoulder tendinopathies. The trial enrolls adults with shoulder tendinopathy and randomizes them to receive either standard balneophysiotherapy or the same treatment supplemented with PEMF (SIS) therapy.
Healthcare providers and clinical researchers should note that this trial examines a specific electromagnetic field intervention (Super Inductive System) in combination with balneophysiotherapy, with primary endpoints including pain intensity and pressure pain threshold, and secondary endpoints covering function, muscle strength, psychological status, and quality of life. The study uses validated clinical instruments at three time points: baseline, discharge, and 4-week follow-up.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PEMF Therapy in Shoulder Tendinopathy
N/A NCT07550543 Kind: NA Apr 24, 2026
Abstract
The goal of this clinical trial is to evaluate whether pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS), integrated into a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies.
The main questions it aims to answer are:
- Does the addition of PEMF (SIS) therapy reduce pain intensity and improve pressure pain threshold compared to standard balneophysiotherapy?
- Does PEMF (SIS) therapy improve shoulder function, muscle strength, psychological status, and quality of life? The study will compare a multimodal rehabilitation program supplemented with PEMF (SIS) therapy to standard balneophysiotherapy to determine whether the addition of PEMF (SIS) provides superior clinical outcomes.
Participants will:
- Undergo a multimodal rehabilitation program including balneophysiotherapy
- Be assigned to receive either standard treatment or treatment supplemented with PEMF (SIS) therapy
- Be evaluated at baseline (admission), immediately after treatment completion (discharge), and at 4 weeks after treatment using validated clinical instruments assessing pain, function, pressure pain threshold, muscle strength, psychological status, depressive symptoms, and quality of life.
Conditions: Shoulder Tendinopathy
Interventions: Nanopulsed Electromagnetic Field Therapy (SIS), Balneophysiotherapy
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.